199 related articles for article (PubMed ID: 3489912)
1. Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse.
Perry TL; Yong VW; Wall RA; Jones K
Neurosci Lett; 1986 Sep; 69(3):285-9. PubMed ID: 3489912
[TBL] [Abstract][Full Text] [Related]
2. 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets.
Perry TL; Jones K; Hansen S; Wall RA
Neurosci Lett; 1987 Mar; 75(1):65-70. PubMed ID: 3106859
[TBL] [Abstract][Full Text] [Related]
3. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM
Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues.
Fries DS; de Vries J; Hazelhoff B; Horn AS
J Med Chem; 1986 Mar; 29(3):424-7. PubMed ID: 3485197
[TBL] [Abstract][Full Text] [Related]
5. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ
Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
Mori S; Fujitake J; Kuno S; Sano Y
Neurosci Lett; 1988 Jul; 90(1-2):57-62. PubMed ID: 2901058
[TBL] [Abstract][Full Text] [Related]
7. Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse.
Perry TL; Yong VW; Clavier RM; Jones K; Wright JM; Foulks JG; Wall RA
Neurosci Lett; 1985 Sep; 60(2):109-14. PubMed ID: 3877260
[TBL] [Abstract][Full Text] [Related]
8. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.
Ricaurte GA; Langston JW; Delanney LE; Irwin I; Peroutka SJ; Forno LS
Brain Res; 1986 Jun; 376(1):117-24. PubMed ID: 3487376
[TBL] [Abstract][Full Text] [Related]
9. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae.
Trevor AJ; Castagnoli N; Caldera P; Ramsay RR; Singer TP
Life Sci; 1987 Feb; 40(8):713-9. PubMed ID: 3492651
[TBL] [Abstract][Full Text] [Related]
10. Toxic influence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice.
Ren JP; Zhao YW; Sun XJ
Chin Med J (Engl); 2009 Oct; 122(19):2366-71. PubMed ID: 20079141
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC
Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685
[TBL] [Abstract][Full Text] [Related]
12. Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
Heikkila RE; Sieber BA; Manzino L; Sonsalla PK
Mol Chem Neuropathol; 1989 Jun; 10(3):171-83. PubMed ID: 2669769
[No Abstract] [Full Text] [Related]
13. Mesolimbic dopaminergic neurons are not spared by MPTP neurotoxicity in mice.
Melamed E; Rosenthal J; Globus M; Cohen O; Frucht Y; Uzzan A
Eur J Pharmacol; 1985 Aug; 114(1):97-100. PubMed ID: 3876229
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Youngster SK; Sonsalla PK; Heikkila RE
J Neurochem; 1987 Mar; 48(3):929-34. PubMed ID: 3492590
[TBL] [Abstract][Full Text] [Related]
15. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
[TBL] [Abstract][Full Text] [Related]
16. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
[TBL] [Abstract][Full Text] [Related]
17. Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Perry TL; Yong VW; Hansen S; Jones K; Bergeron C; Foulks JG; Wright JM
J Neurol Sci; 1987 Nov; 81(2-3):321-31. PubMed ID: 3121800
[TBL] [Abstract][Full Text] [Related]
18. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
19. Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).
Martinovits G; Melamed E; Cohen O; Rosenthal J; Uzzan A
Neurosci Lett; 1986 Aug; 69(2):192-7. PubMed ID: 3489911
[TBL] [Abstract][Full Text] [Related]
20. Studies on semirigid tricyclic analogues of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Booth RG; Trevor A; Singer TP; Castagnoli N
J Med Chem; 1989 Feb; 32(2):473-7. PubMed ID: 2783613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
